As of April 19, 2025, Reneo Pharmaceuticals (RPHM) has a market cap of $60.840 million USD. According to our data, Reneo Pharmaceuticals is ranked No.7935 in global market value.
Year | Market Cap | %Change |
---|---|---|
Oct 04, 2024 | $60.84 M |
13.75%
|
Dec 29, 2023 | $53.49 M |
-31.33%
|
Dec 30, 2022 | $77.89 M |
-72.75%
|
Dec 31, 2021 | $0.29 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
![]() USA
|
![]() PTC Therapeutics
PTCT
|
$3.74 B |
-0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.35 B |
0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
![]() USA
|
![]() Amicus Therapeutics
FOLD
|
$2.10 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.67 B |
-0.000 M
|
![]() USA
|
![]() Solid Biosciences
SLDB
|
$0.20 B |
0.000 M
|
![]() USA
|
![]() Boundless Bio
BOLD
|
$31.67 M |
0.000 M
|
![]() USA
|
![]() Cytokinetics
CYTK
|
$4.71 B |
-0.000 M
|
![]() USA
|
Market Cap | = | RPHM Stock Price | * | RPHM Shares Outstanding |
= | $18.20 | * | 3.34 M | |
= | $60.84 M |